72 related articles for article (PubMed ID: 8197745)
1. Intraoperative use of rtPA for subarachnoid hemorrhage.
Schmidt JH; Christenson JT
W V Med J; 1994 Mar; 90(3):98-100. PubMed ID: 8197745
[TBL] [Abstract][Full Text] [Related]
2. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
3. Intracisternal rt-PA during early surgery for aneurysmal subarachnoid hemorrhage: an Italian report.
Tomasello F; D'Avella D
J Neurosurg Sci; 1993 Jun; 37(2):71-5. PubMed ID: 8301373
[TBL] [Abstract][Full Text] [Related]
4. Influence of intraoperative using of recombinant tissue plasminogen activator on the development of cerebral angiospasm after subarachnoid haemorrhage in patients with ruptured intracranial aneurysms.
Górski R; Zabek M; Jarmuzek P
Neurol Neurochir Pol; 2000; 34(6 Suppl):41-7. PubMed ID: 11452854
[TBL] [Abstract][Full Text] [Related]
5. Treatment of intraventricular hemorrhage with intraventricular administration of recombinant tissue plasminogen activator A clinical study of 18 cases.
Vereecken KK; Van Havenbergh T; De Beuckelaar W; Parizel PM; Jorens PG
Clin Neurol Neurosurg; 2006 Jul; 108(5):451-5. PubMed ID: 16139422
[TBL] [Abstract][Full Text] [Related]
6. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
Stolke D; Seifert V
Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of single intracisternal bolus injection of recombinant tissue plasminogen activator to prevent delayed cerebral vasospasm after experimental subarachnoid hemorrhage.
Seifert V; Eisert WG; Stolke D; Goetz C
Neurosurgery; 1989 Oct; 25(4):590-8. PubMed ID: 2507953
[TBL] [Abstract][Full Text] [Related]
8. Cerebral autoregulation dynamics in acute ischemic stroke after rtPA thrombolysis.
Reinhard M; Wihler C; Roth M; Harloff A; Niesen WD; Timmer J; Weiller C; Hetzel A
Cerebrovasc Dis; 2008; 26(2):147-55. PubMed ID: 18560218
[TBL] [Abstract][Full Text] [Related]
9. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
10. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
11. [Intraoperative radical clot removal therapy using a bipolar irrigation system for prevention of cerebral vasospasm following subarachnoid hemorrhage].
Tsuruno T
No Shinkei Geka; 2005 Apr; 33(4):343-8. PubMed ID: 15830540
[TBL] [Abstract][Full Text] [Related]
12. The impact of microsurgical fenestration of the lamina terminalis on shunt-dependent hydrocephalus and vasospasm after aneurysmal subarachnoid hemorrhage.
Komotar RJ; Hahn DK; Kim GH; Khandji J; Mocco J; Mayer SA; Connolly ES
Neurosurgery; 2008 Jan; 62(1):123-32; discussion 132-4. PubMed ID: 18300899
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal fibrinolysis using recombinant tissue plasminogen activator (rTPA) for prevention of cerebral vasospasm and delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage. Experimental and clinical data.
Seifert V
Neurol Res; 1994 Feb; 16(1):54-8. PubMed ID: 7913533
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of MRI-based selection for recombinant tissue plasminogen activator treatment: responder analysis of outcome in the 3-hour time window.
Sølling C; Hjort N; Ashkanian M; Østergaard L; Andersen G
Cerebrovasc Dis; 2009; 27(3):223-9. PubMed ID: 19176954
[TBL] [Abstract][Full Text] [Related]
15. Perioperative fever and outcome in surgical patients with aneurysmal subarachnoid hemorrhage.
Todd MM; Hindman BJ; Clarke WR; Torner JC; Weeks JB; Bayman EO; Shi Q; Spofford CM;
Neurosurgery; 2009 May; 64(5):897-908; discussion 908. PubMed ID: 19404150
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue plasminogen activator (rtPA) for the treatment of hepatic veno-occlusive disease (VOD).
Kulkarni S; Rodriguez M; Lafuente A; Mateos P; Mehta J; Singhal S; Saso R; Tait D; Treleaven JG; Powles RL
Bone Marrow Transplant; 1999 Apr; 23(8):803-7. PubMed ID: 10231143
[TBL] [Abstract][Full Text] [Related]
17. Coiling versus clipping for the treatment of aneurysmal subarachnoid hemorrhage: a longitudinal investigation into cognitive outcome.
Frazer D; Ahuja A; Watkins L; Cipolotti L
Neurosurgery; 2007 Mar; 60(3):434-41; discussion 441-2. PubMed ID: 17327787
[TBL] [Abstract][Full Text] [Related]
18. Timing of aneurysm surgery in subarachnoid haemorrhage--an observational study in The Netherlands.
Nieuwkamp DJ; de Gans K; Algra A; Albrecht KW; Boomstra S; Brouwers PJ; Groen RJ; Metzemaekers JD; Nijssen PC; Roos YB; Tulleken CA; Vandertop WP; van Gijn J; Vos PE; Rinkel GJ
Acta Neurochir (Wien); 2005 Aug; 147(8):815-21. PubMed ID: 15944811
[TBL] [Abstract][Full Text] [Related]
19. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage.
Sanchez-Peña P; Pereira AR; Sourour NA; Biondi A; Lejean L; Colonne C; Boch AL; Al Hawari M; Abdennour L; Puybasset L
Crit Care Med; 2008 Aug; 36(8):2267-73. PubMed ID: 18596638
[TBL] [Abstract][Full Text] [Related]
20. The impact of imbalances in baseline stroke severity on outcome in the National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study.
Kwiatkowski T; Libman R; Tilley BC; Lewandowski C; Grotta JC; Lyden P; Levine SR; Brott T;
Ann Emerg Med; 2005 Apr; 45(4):377-84. PubMed ID: 15795715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
